Clinical trial · Interventional
Efficacy and Acceptability of Thermal Ablation in the Treatment of Cervical Neoplasia
NCT05453318CI-TRIAL-00059608completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Longitudinal study in two referral centers in Morocco to evaluate the effectiveness, the acceptability and safety of thermal ablation in the treatment of cervical neoplasia.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Neoplasm | Cervical Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Treatment of cervical neoplasia by thermal ablation | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Thermal ablation Arm
- description
- Treatment of cervical neoplasia by thermal ablation
- interventionNames
- Procedure: Treatment of cervical neoplasia by thermal ablation
Primary outcomes (1)
- measure
- Cure rate based on colposcopy and histology assessment
- timeFrame
- 1 year
- description
- Cure rate is assessed after 1 year of treatment by colposcopy. Persistent or recurrent lesions are treated by thermal ablation, excision or hysterectomy according to the lesion size and characteristics.
Secondary outcomes (3)
- measure
- Acceptability of thermal ablation in terms of adverse events
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Women having been screened positive at VIA at the primary health center and referred to the diagnosis centre of Fez and Taza for ablative treatment by thermal ablation Exclusion Criteria: * Lesion occupying the 4 quadrants of the cervix * Not visible squamous columnar junction (not Type 1 TZ (transformation zone)) * Vaginal or endocervical lesion * Lesion subjective of cervical cancer
References
Publications (0)
Data not yet available
No reference posted for this study.